Liposomes conjugated with anti-BRAF antibodies are commonly used in lung cancer treatment for targeted drug delivery, aiming to enhance therapeutic efficacy. These liposomes can precisely deliver drugs to cancer cells by binding to specific targets, thereby improving the effectiveness of targeted therapy. Studies have shown that the combination of antibodies and drugs in cancer gene therapy helps to overcome the limitations of traditional methods.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-122-F(E) | Recombinant Anti-human BRAF Antibody Fab Fragment | IF, Neut, FuncS | Fab |
MHH-122-F(E) | Recombinant Human Anti-human BRAF Antibody Fab Fragment | ELISA, WB, Neut, FuncS | Fab |
There are currently no Customer reviews or questions for VS-1024-FY37. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.